Aug 9
|
3 Stocks Retirees Should Absolutely Love
|
Aug 8
|
Abbott's EPD Growth Beats Market Trends: Here's How to Play the Stock
|
Aug 8
|
Hologic's Diagnostics Arm Set for Long-Term Upside: What's Behind It?
|
Aug 8
|
Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting
|
Aug 7
|
Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
|
Aug 7
|
Inside Dexcom’s strategy to stay ahead in the $13.6bn CGM market
|
Aug 6
|
Tandem Diabetes Care Announces Second Quarter 2025 Financial Results and Provides 2025 Annual Guidance
|
Aug 6
|
Senseonics Holdings, Inc. Reports Second Quarter Financial Results
|
Aug 6
|
Abbott's Q2 Diabetes Care Sales Rise 19.6%: What's Backing It?
|
Aug 6
|
Abbott Laboratories' (NYSE:ABT) Earnings Are Of Questionable Quality
|
Aug 6
|
Medical Devices & Supplies - Diversified Stocks Q2 Highlights: Abbott Laboratories (NYSE:ABT)
|
Aug 4
|
QuidelOrtho Corporation (QDEL): A Bull Case Theory
|
Aug 4
|
Abbott Laboratories (NYSE:ABT) Is Looking To Continue Growing Its Returns On Capital
|
Aug 1
|
2 Top Stocks to Buy Now If You Want Decades of Passive Income
|
Jul 31
|
AbbVie’s (NYSE:ABBV) Q2: Beats On Revenue
|
Jul 31
|
UBS Shrugs Abbott Laboratories’ (ABT) Diagnostic Weakness Affirms ‘Buy’ Rating
|
Jul 30
|
Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic
|
Jul 29
|
Rapid Expansion and Innovation Drive $36 Billion Global Point-of-Care Diagnostics Market, Says New Kalorama Report
|
Jul 29
|
A new infant formula seven years in the making is hitting the $2 billion market
|
Jul 29
|
Europe Defibrillator Market Forecast and Company Analysis Report 2025-2033 Featuring Medtronic, Philips, Nihon Kohden, Boston Scientific, Stryker, Asahi Kasei, LivaNova, and Abbott
|